相关实验视频
Updated: May 9, 2026

11:19
Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
亚喀拉西亚亚喀拉西亚是指亚喀拉西亚的一个地区
Guy E Boeckxstaens1, Giovanni Zaninotto2, Joel E Richter3
1Department of Gastroenterology, Translational Research Center for Gastrointestinal Disorders (TARGID), University Hospital Leuven, Catholic University of Leuven, Leuven, Belgium.
Lancet (London, England)
|July 23, 2013
概括
阿哈拉西亚是一种食道运动障碍,涉及神经损失和关功能受损. 目前的治疗方法,如气动扩张和赫勒肌肉切除术是有效的,口腔内镜肌肉切除术作为一种新的选择.
科学领域:
- 胃肠病学 胃肠病学
- 食道运动障碍 食道运动障碍
- 免疫学 免疫学 免疫学
背景情况:
- 阿哈拉西亚是一种罕见的食道运动障碍,其特征是肠道神经元的损失.
- 这种神经元损失导致周围静脉缺失,并损害了下食道关节的放松.
- 确切的原因尚不清楚,但病毒引发的免疫反应在易受感染的个体中是相关的.
研究的目的:
- 总结一下目前对阿卡拉西亚的理解.
- 概述阿喀拉西亚的临床表现和与之相关的风险.
- 审查当前和新兴的治疗阿喀拉西亚的选择.
主要方法:
- 关于阿喀拉西亚病理生理学,临床特征和治疗方式的文献综述.
- 分析当前的治疗标准,包括气动扩张和赫勒肌切除术.
- 包括新兴的最小侵入性技术,如通过口腔内镜肌切除术.
主要成果:
- 阿哈拉西亚导致消化不良,反,胸痛,体重减轻,并增加食道癌症的风险.
- 肺部扩张和赫勒肌切除术是具有相似成功率的已知治疗方法.
- 通过口腔内镜肌切除术是一种新的,最少的侵入性选择,尽管直接比较试验正在进行中.
结论:
- 阿哈拉西亚是一种复杂的食道疾病,对患者有重大影响.
- 已建立的治疗方法提供了有效的管理,而新的最少侵入性的选择显示了希望.
- 需要进一步的研究,包括随机试验,以将新型治疗与当前标准进行比较.
相关概念视频
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Gastrointestinal Motility Disorders
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Hiatal Hernia
A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...
Pyloric Obstruction
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...

